218 related articles for article (PubMed ID: 31839604)
41. Autoantibodies as potential biomarkers for breast cancer.
Zhong L; Ge K; Zu JC; Zhao LH; Shen WK; Wang JF; Zhang XG; Gao X; Hu W; Yen Y; Kernstine KH
Breast Cancer Res; 2008; 10(3):R40. PubMed ID: 18460216
[TBL] [Abstract][Full Text] [Related]
42. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H
Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375
[TBL] [Abstract][Full Text] [Related]
43. Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer.
Cheng Y; Li Q; Sun G; Li T; Zou Y; Ye H; Wang K; Shi J; Wang P
Sci Rep; 2024 Apr; 14(1):9757. PubMed ID: 38684875
[TBL] [Abstract][Full Text] [Related]
44. Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma.
Sun G; Ye H; Yang Q; Zhu J; Qiu C; Shi J; Dai L; Wang K; Zhang J; Wang P
Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):e582-e592. PubMed ID: 37433700
[TBL] [Abstract][Full Text] [Related]
45. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.
Ummanni R; Duscharla D; Barett C; Venz S; Schlomm T; Heinzer H; Walther R; Bokemeyer C; Brümmendorf TH; Murthy PV; Balabanov S
J Proteomics; 2015 Apr; 119():218-29. PubMed ID: 25724726
[TBL] [Abstract][Full Text] [Related]
46. Anti-heat shock protein autoantibody profiling in breast cancer using customized protein microarray.
Shi L; Gehin T; Chevolot Y; Souteyrand E; Mangé A; Solassol J; Laurenceau E
Anal Bioanal Chem; 2016 Feb; 408(5):1497-506. PubMed ID: 26715250
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera.
Lu H; Ladd J; Feng Z; Wu M; Goodell V; Pitteri SJ; Li CI; Prentice R; Hanash SM; Disis ML
Cancer Prev Res (Phila); 2012 Aug; 5(8):1036-43. PubMed ID: 22715141
[TBL] [Abstract][Full Text] [Related]
48. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.
Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R
Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402
[No Abstract] [Full Text] [Related]
49. Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens.
Shi FD; Zhang JY; Liu D; Rearden A; Elliot M; Nachtsheim D; Daniels T; Casiano CA; Heeb MJ; Chan EK; Tan EM
Prostate; 2005 May; 63(3):252-8. PubMed ID: 15538718
[TBL] [Abstract][Full Text] [Related]
50. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
Chen Y; Zhou Y; Qiu S; Wang K; Liu S; Peng XX; Li J; Tan EM; Zhang JY
Cancer Lett; 2010 Mar; 289(1):32-9. PubMed ID: 19683863
[TBL] [Abstract][Full Text] [Related]
51. Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.
Li L; Wang K; Dai L; Wang P; Peng XX; Zhang JY
Mol Med Rep; 2008; 1(4):589-94. PubMed ID: 20523766
[TBL] [Abstract][Full Text] [Related]
52. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
[TBL] [Abstract][Full Text] [Related]
53. Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.
Chen M; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Xue F; Huang Y
Int J Med Sci; 2020; 17(17):2744-2750. PubMed ID: 33162802
[No Abstract] [Full Text] [Related]
54. Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens.
Evans RL; Pottala JV; Egland KA
Cancer Prev Res (Phila); 2014 May; 7(5):545-55. PubMed ID: 24641868
[TBL] [Abstract][Full Text] [Related]
55. Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer.
Qiu C; Wang B; Wang P; Wang X; Ma Y; Dai L; Shi J; Wang K; Sun G; Ye H; Zhang J
Cancer Sci; 2021 Aug; 112(8):3388-3400. PubMed ID: 34115421
[TBL] [Abstract][Full Text] [Related]
56. Establishment and validation of an immunodiagnostic model for prediction of breast cancer.
Qiu C; Wang P; Wang B; Shi J; Wang X; Li T; Qin J; Dai L; Ye H; Zhang J
Oncoimmunology; 2020; 9(1):1682382. PubMed ID: 32002291
[TBL] [Abstract][Full Text] [Related]
57. Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality.
Evans RL; Pottala JV; Nagata S; Egland KA
BMC Cancer; 2018 Jan; 18(1):119. PubMed ID: 29386014
[TBL] [Abstract][Full Text] [Related]
58. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis.
Koziol JA; Zhang JY; Casiano CA; Peng XX; Shi FD; Feng AC; Chan EK; Tan EM
Clin Cancer Res; 2003 Nov; 9(14):5120-6. PubMed ID: 14613989
[TBL] [Abstract][Full Text] [Related]
59. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.
Shi JX; Qin JJ; Ye H; Wang P; Wang KJ; Zhang JY
Expert Rev Mol Diagn; 2015 Jun; 15(6):829-52. PubMed ID: 25959246
[TBL] [Abstract][Full Text] [Related]
60. Alpha 2HS-glycoprotein, a tumor-associated antigen (TAA) detected in Mexican patients with early-stage breast cancer.
Fernández-Grijalva AL; Aguilar-Lemarroy A; Jave-Suarez LF; Gutiérrez-Ortega A; Godinez-Melgoza PA; Herrera-Rodríguez SE; Mariscal-Ramírez I; Martínez-Velázquez M; Gawinowicz MA; Martínez-Silva MG; Cruz-Ramos JA; Hernández-Gutiérrez R
J Proteomics; 2015 Jan; 112():301-12. PubMed ID: 25106788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
